---
figid: PMC7981362__13205_2021_2738_Fig1_HTML
figtitle: Insulin receptor substance-1 modulating PI3K/Akt insulin signaling pathway
  in Alzheimer’s disease
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC7981362
filename: 13205_2021_2738_Fig1_HTML.jpg
figlink: /pmc/articles/PMC7981362/figure/Fig1/
number: F1
caption: Schematic representation of the shared mechanisms between AD and T2DM. IR
  could stimulate amyloid deposition by reducing the degradation of Aβ by IDE and
  clearance of Aβ by impairing BBB. Furthermore, IR makes insulin signaling pathway
  conduction abnormal, leading to PI3K/Akt signaling pathway and its downstream molecules
  dysfunction. The impaired insulin signaling pathway elicits oxidative stress, energy
  metabolism dysfunction, neuroinflammation, mitochondrial dysfunction, autophagy
  dysfunction, and neuronal death ultimately, all of which promote cognitive impairment
  in AD. AD Alzheimer’s disease, T2DM Type 2 diabetes mellitus, IR Insulin resistance,
  Aβ amyloid-β peptide, IDE insulin-degrading enzyme, BBB blood–brain barrier
papertitle: Role of insulin receptor substance-1 modulating PI3K/Akt insulin signaling
  pathway in Alzheimer’s disease.
reftext: Mingcui Zheng, et al. 3 Biotech. 2021 Apr;11(4):179.
year: '2021'
doi: 10.1007/s13205-021-02738-3
journal_title: 3 Biotech
journal_nlm_ta: 3 Biotech
publisher_name: Springer International Publishing
keywords: Alzheimer’s disease | Anti-diabetic drugs | Brain insulin resistance | IRS-1
  | IRS-1 phosphorylation | PI3K/Akt insulin signaling pathway
automl_pathway: 0.9507756
figid_alias: PMC7981362__F1
figtype: Figure
redirect_from: /figures/PMC7981362__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7981362__13205_2021_2738_Fig1_HTML.html
  '@type': Dataset
  description: Schematic representation of the shared mechanisms between AD and T2DM.
    IR could stimulate amyloid deposition by reducing the degradation of Aβ by IDE
    and clearance of Aβ by impairing BBB. Furthermore, IR makes insulin signaling
    pathway conduction abnormal, leading to PI3K/Akt signaling pathway and its downstream
    molecules dysfunction. The impaired insulin signaling pathway elicits oxidative
    stress, energy metabolism dysfunction, neuroinflammation, mitochondrial dysfunction,
    autophagy dysfunction, and neuronal death ultimately, all of which promote cognitive
    impairment in AD. AD Alzheimer’s disease, T2DM Type 2 diabetes mellitus, IR Insulin
    resistance, Aβ amyloid-β peptide, IDE insulin-degrading enzyme, BBB blood–brain
    barrier
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ab
  - Appl
  - Myb
  - Pi3K21B
  - Taf5
  - l(1)G0020
  - Taf4
  - Pi3K92E
  - Rpn2
  - Sap-r
  - Pi3K59F
  - Pi3K68D
  - sgg
  - tau
  - bsk
  - Ide
  - Akt
  - Mtor
  - Tor
  - abt
  - foxo
  - egr
  - APP
  - SUCLA2
  - IRS1
  - PIK3R1
  - PIK3R2
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - CUX1
  - SART3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - GSK3A
  - GSK3B
  - MAPT
  - MAPK8
  - MAPK9
  - MAPK10
  - IDE
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - TNF
---
